InsiderTrades.com logo

APRE Insider Trading

Insider Ownership Percentage: 13.63%
Insider Buying (Last 12 Months): $10,120.00
Insider Selling (Last 12 Months): $0.00

Aprea Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aprea Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aprea Therapeutics Share Price & Price History

Current Price: $1.06
Price Change: ▲ Price Increase of +0.03 (2.91%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for APRE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aprea Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/3/2025Oren GiladCEOBuy5,500$1.84$10,120.00345,620View SEC Filing Icon  
10/23/2024Oren GiladCEOBuy500$3.92$1,960.00333,395View SEC Filing Icon  
10/18/2024Marc DueyDirectorSell6,462$4.58$29,595.96233,651View SEC Filing Icon  
10/16/2024Marc DueyDirectorBuy30,000$4.39$131,700.00240,113View SEC Filing Icon  
10/14/2024Marc DueyDirectorBuy190$2.58$490.20210,113View SEC Filing Icon  
10/14/2024Oren GiladCEOBuy1,000$2.59$2,590.00332,645View SEC Filing Icon  
10/11/2024Bernd R SeizingerDirectorBuy10,000$2.68$26,800.0044,730View SEC Filing Icon  
10/10/2024John P HamillCFOBuy450$2.61$1,174.5019,318View SEC Filing Icon  
10/10/2024Oren GiladCEOBuy150$2.54$381.00331,645View SEC Filing Icon  
3/13/2024Bernd R SeizingerDirectorBuy6,860$7.29$50,009.4033,685View SEC Filing Icon  
3/13/2024John P HamillCFOBuy1,010$7.29$7,362.9015,503View SEC Filing Icon  
3/13/2024Oren GiladCEOBuy2,000$7.29$14,580.00324,770View SEC Filing Icon  
6/6/2023Bernd R SeizingerDirectorBuy4,068$3.63$14,766.8420,296View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aprea Therapeutics (NASDAQ:APRE)

34.19% of Aprea Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at APRE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aprea Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2025Exome Asset Management LLC28,972$59K0.1%-77.4%0.524%Search for SEC Filing on Google Icon
5/14/2025Stonepine Capital Management LLC102,242$0.21M0.2%-31.5%1.851%Search for SEC Filing on Google Icon
2/17/2025Stonepine Capital Management LLC149,221$0.49M0.4%+8.8%2.748%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets13,011$43K0.0%N/A0.240%Search for SEC Filing on Google Icon
2/12/2025Landscape Capital Management L.L.C.35,328$0.12M0.0%N/A0.651%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC16,052$53K0.0%N/A0.296%Search for SEC Filing on Google Icon
8/21/2024Stonepine Capital Management LLC137,174$0.56M0.5%N/A2.526%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP11,071$45K0.0%N/A0.204%Search for SEC Filing on Google Icon
5/15/2023AIGH Capital Management LLC345,000$1.53M0.6%N/A9.244%Search for SEC Filing on Google Icon
5/15/2023Sio Capital Management LLC280,000$1.24M0.6%N/A7.503%Search for SEC Filing on Google Icon
5/12/2022Gyon Technologies Capital Management LP20,570$38K0.0%N/A0.094%Search for SEC Filing on Google Icon
5/12/2022Magnus Financial Group LLC14,856$28K0.0%-56.3%0.068%Search for SEC Filing on Google Icon
2/15/2022Kennedy Capital Management Inc.336,730$0.97M0.0%-1.7%1.569%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC142,600$0.41M0.0%+62.5%0.664%Search for SEC Filing on Google Icon
2/10/2022Magnus Financial Group LLC33,981$98K0.0%N/A0.158%Search for SEC Filing on Google Icon
11/16/2021Verition Fund Management LLC20,101$0.10M0.0%N/A0.094%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC198,339$1.01M0.0%+89.9%0.936%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.144,758$0.74M0.0%+131.4%0.683%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.354,275$1.81M0.0%-0.9%1.672%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley1,019,776$4.98M0.0%+2.2%4.813%Search for SEC Filing on Google Icon
8/16/2021State Street Corp40,832$0.20M0.0%-67.2%0.193%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.62,546$0.31M0.0%-14.4%0.295%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp32,530$0.16M0.0%-69.2%0.154%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aprea Therapeutics logo
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.
Read More on Aprea Therapeutics

Today's Range

Now: $1.06
Low: $0.99
High: $1.14

50 Day Range

MA: $1.35
Low: $1.02
High: $1.65

52 Week Range

Now: $1.06
Low: $0.96
High: $5.00

Volume

88,338 shs

Average Volume

70,900 shs

Market Capitalization

$6.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Who are the company insiders with the largest holdings of Aprea Therapeutics?

Aprea Therapeutics' top insider shareholders include:
  1. Oren Gilad (CEO)
  2. Marc Duey (Director)
  3. Bernd R Seizinger (Director)
  4. John P Hamill (CFO)
Learn More about top insider investors at Aprea Therapeutics.